mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.1 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
0.058 |
0.1 |